Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Stryker Corporation SYK

Healthcare  —  Medical Devices
272.36 2.61 0.97% as of 25 Sep
Market cap
$103.9B
P/E
28.0×
S&P 500 Member Dividend Champion (10y) Cash Flow Champion (3y) Revenue Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Stryker Corporation (SYK) EV/EBITDA

As of 25 September 2026, Stryker Corporation (SYK) trades at a EV/EBITDA of 17.2×. Over the past ten years it has ranged from 14.6× (January 2016) to 37.9× (April 2021); the current reading is higher than 4% of that period. That is above the Medical Devices industry median of 11.8× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 24.0× (22.18%)
FY2024 30.9× 23.99%
FY2023 24.9× (8.25%)
FY2022 27.1× (12.06%)
FY2021 30.9× (9.06%)
FY2020 33.9× 39.06%
FY2019 24.4× 22.76%
FY2018 19.9× (7.98%)
FY2017 21.6× 21.92%
FY2016 17.7× 14.56%

Quarterly

Period EV/EBITDA Change
Jun 2026 19.6× (11.67%)
Mar 2026 22.2× (7.76%)
Dec 2025 24.0× (25.32%)
Sep 2025 32.2× (8.25%)
42 more quarters

Against its own ten years

Low 14.6× High 37.9×
Ten-year median 25.0×
Current reading's percentile 4

EV/EBITDA against peers

Company EV/EBITDA
PHG Koninklijke Philips N.V. compare 8.6×
GEHC GE HealthCare Technologies Inc. compare 11.9×
STE STERIS plc compare 13.4×
MDT Medtronic PLC compare 13.7×
BSX Boston Scientific Corporation compare 13.8×
SYK Stryker Corporation 17.2×
ABT Abbott Laboratories compare 18.8×
DXCM DexCom, Inc. compare 23.2×
EW Edwards Lifesciences Corporation compare 28.6×
Medical Devices industry median 11.8×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on SYK